skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Would the listed companies all fall under the Tech sector?

Thanks,
Brent
Read Answer Asked by Brent on February 21, 2020
Q: Gentlemen,
I hold the above four REIT's. I plan to sell REI.UN. With the proceeds and new cash I would like to increase the HR.UN and BPY:US positions and add two additional REIT's. For these I am considering DIR.UN, FCR.UN, IIP.UN. or any of your suggestions. These 5 REIT's would represent 10% of my portfolio.
I appreciate you input.
Thank you,
Werner
Read Answer Asked by Werner on February 21, 2020
Q: Hi team,
Looking for growth, grateful for your views on DVA, MTB and CHTR. Would you buy them now ? If not, what would be better alternatives ?

Gratefully yours,

Jacques IDS
Read Answer Asked by Jacques on February 21, 2020
Q: Dearr 5i
What are the expected earnings growth rates for AMAT , AMD and NVDA over the next 1-2 years and which would you recommend for an RRSP assuming a balanced portfolio .
Thanks
Bill C.
Read Answer Asked by Bill on February 21, 2020
Q: I just received an email from Citron talking about SDGR. They feel it is the second coming of TSLA but of course, in a different industry.
They are a brand new IPO and are up 20% today, but would this be worth purchasing in the event that it pulls back to prior to the letter and held for a period of time.
In a nutshell they recap it thusly:

"Through use of artificial intelligence and a world class scientific team that is unmatched by ANY public company, Schrodinger has created a software platform that integrates predictive physics-based methods with machine learning to become the leader in molecular simulation that 1) reduces the average time and cost required to identify a drug development candidate and 2) increases the probability of drug discovery programs entering clinical development.

With the global pharma industry spending approximately $180 billion on R&D annually, this innovative software platform is completely disrupting the drug development process."

Would you invest in this concept yourselves, once you research more about it.? I know its not a p/e , value play it may or may not be TSLA of 10 years ago.

Thanks

Sheldon
Read Answer Asked by Sheldon on February 21, 2020
Q: Do you have a view on this company. Many years ago in a previous job I dealt with them extensively but do not recall them pushing their public company status. My experince was they tended to regularly buy out rising competitors. Looking for analysis of the key metrics.
Read Answer Asked by William Ross on February 21, 2020
Q: Hello,

In B.C. and Alberta, Condo Stratas are having difficulty obtaining insurance or insurance premiums are increased substantially. This appears due in part to some insurers leaving B.C. and the value of the properties increasing over the last several years making replacement cost expensive.

Would the REITS that operate in Western Canada have similar issues? I’d be concerned with owning a REIT that runs rental apartments but can’t get insurance on the building.
Looking at particular at CAR.UN and REI.UN.

Thanks
Read Answer Asked by Sarj on February 20, 2020
Q: I'm meeting with my broker tomorrow. My results were over 20% last year. 2019 TSX return was 19%.
I'm still working full time so I find it difficult to manage my portfolio on my own.
I check all of his recommendations on 5i.
Mostly conservative dividend paying stocks. Buying on dips and trimming on rises.
Overall, I'm finding it hard to complain about what he's doing
What should I ask him when we meet tomorrow?
Read Answer Asked by Vern on February 20, 2020
Q: I was wondering what US stocks will do well in the short term.
-Jay
Read Answer Asked by jay on February 20, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!